Nusano: Unlocking the Next $20-30B Market Opportunity in Oncology: Radioisotope Production & Applications
About The Event
Join us for a virtual KOL event with Nusano, featuring Robert Atcher, PhD, MBA, FSNMMI (University of New Mexico) and Martin Pomper, MD, PhD (Johns Hopkins Medicine) who will discuss the technical aspects of isotope production and provide a clinical overview of the therapeutic applications of radioisotopes in oncology.
The event will highlight the rapidly expanding and critically undersupplied medical radioisotopes market, including current limitations and what must be overcome to improve patient care and unlock market potential.
Nusano will discuss how its proprietary particle beam technology is poised to dramatically increase rare isotope supplies – representing the first significant advancement in radioisotope production in decades.
A live question and answer session will follow the formal presentations.